Purchase Order HHSM500200800133P

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $1.7 million delivery order contract to Regimed Medical to procure 240 blister packs of 150 mg nilotinib tablets and 40 blister packs of 200 mg nilotinib tablets in support of the Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program. The firm fixed price contract runs from November 17, 2023 through November 16, 2024 and will be performed in Frederick, Maryland.

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $780,240 delivery order contract to Regimed Medical of Frederick, Maryland. Under the terms of the contract, Regimed Medical will provide 112 blisters of 150mg Nilotinib capsules and 16 blisters of 200mg Nilotinib capsules in support of the DHHS, NIH, NCI, DCTD, CTEP. The fixed price contract runs from September 20, 2023 through September 19, 2024 and will be performed in Frederick,...

This is a delivery order awarded to Regimed Medical, a minority-owned small disadvantaged business located in O'Fallon, Missouri, under a $6.34 million Indefinite Delivery Contract (IDC) with the National Institutes of Health (NIH) National Cancer Institute. The delivery order, valued at $219,850.00, is for the procurement of 200 mg nilotinib tablets to support the NIH's Division of Cancer Treatment and Diagnosis and Cancer Therapy Evaluation Program. This requirement is not set-aside and is...

Lundbeck LLC has been awarded a $10,190.59 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9. The firm fixed price order is for the drug NORTHERA (DROXIDOPA) 300MG and has a completion date of June 6, 2020. Performance will take place in Nashville, Tennessee. No set-aside designation was applied to this order. The Veterans Health Administration oversees the...

The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $260,820 firm fixed price contract to Therapeutic Research Center, LLC for the Dietary Supplement Label Database population from September 26, 2021 through September 25, 2022. The contract was awarded on October 13, 2021 under the Multiple Award Schedule contracting vehicle, with performance to take place in Stockton, California. No set-aside designation was...

This federal contract award, with an ID of SPE2DB22D3016|SPE2DB25FAMD7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a prescription medication, with a ceiling value of $3,041.34 and a completion date of February 5, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside...

The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $382,010.00 Firm Fixed Price Delivery Order contract to Vitae Enim Vitae Scientific, Inc. (VEV Scientific) on September 27, 2024. The contract is for dosage form reprocessing and stability studies of the FX-5A injection drug product under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Chemistry, Manufacturing and Controls (CMC) and related services to support drug product development. The contract...

The Defense Logistics Agency Troop Support Medical awarded a $7,148.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561757742 Nateqlinide 60 mg tablets in quantities of 30 tablets per unit. Performance will take place in Conshohocken, Pennsylvania over a period of one day, from August 9th through August 10th, 2023. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation, will serve as the prime contractor on this...

The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $2.4 million delivery order against the Toxicology of Drugs Developed for Cancer Patients master IDIQ contract to IIT Research Institute. Under this order, IIT Research Institute will provide toxicology services to support the preclinical development of EIF4A inhibitors rocaglamide and didesmethylrocaglamide from September 2020 through September 2023 in...

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of a pharmaceutical product called NITHIODOTE 300 MG-12.5 GRAM 60ML. The contract has a potential value of $2,506.80 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of...